Patents On Breast, Ovarian Cancer Genes Invalidated

| Apr 01, 2010

In a ruling that could have “far-reaching” implications for genetic research and the medical industry, a U.S. District Judge Robert Sweet on Monday invalidated seven patents related to the BRCA1 and BRCA2 genes, mutations of which have been linked to breast and ovarian cancer, the New York Times reports (Pollack/Schwartz, New York Times, 3/29)…

Related Posts:

  1. Judge Hears Arguments In Challenge To Patents On Genes Tied To Breast, Ovarian Cancer
  2. Court Rules Against Gene Patents
  3. Joint Study By Rosetta Genomics And NYU Langone Medical Center Identifies Single MicroRNA Biomarker For Prognosis Of Mesothelioma Patients
  4. New Research Could Help Provide Answers To Mesothelioma, England
  5. Today’s Opinions And Editorials

Filed Under: Medical Malpractice